2013 annual financial data
Edwards Lifesciences 2013 Operating cash flow growth
Direct answer
Operating cash flow growth was 26.46%.
Operating income was 433,000,000 USD and net income was 391,700,000 USD.
Operating cash flow was 472,700,000 USD.
Get free Edwards Lifesciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2,045,500,000 USD
- Operating income
- 433,000,000 USD
- Net income
- 391,700,000 USD
- Operating cash flow
- 472,700,000 USD